South Korea Drug Discovery Outsourcing Market Size & Outlook
Global Market
Related Markets
South Korea drug discovery outsourcing market highlights
- The South Korea drug discovery outsourcing market generated a revenue of USD 94.1 million in 2025 and is expected to reach USD 197.2 million by 2033.
- The South Korea market is expected to grow at a CAGR of 9.8% from 2026 to 2033.
- In terms of segment, lead identification & candidate optimization was the largest revenue generating workflow in 2025.
- Other Associated Workflow is the most lucrative workflow segment registering the fastest growth during the forecast period.
Drug discovery outsourcing market data book summary
| Market revenue in 2025 | USD 94.1 million |
| Market revenue in 2033 | USD 197.2 million |
| Growth rate | 9.8% (CAGR from 2026 to 2033) |
| Largest segment | Lead identification & candidate optimization |
| Fastest growing segment | Other Associated Workflow |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Target Identification & Screening, Target Validation & Functional Informatics, Lead Identification & Candidate Optimization, Preclinical Development, Other Associated Workflow |
| Key market players worldwide | Albany Molecular Research, Evotec SE, Labcorp Holdings Inc, GenScript ProBio, Pharmaceutical Product Development, Charles River Laboratories International Inc, Wuxi AppTec Co Ltd, Merck & Co Inc, Thermo Fisher Scientific Inc, Dalton Pharma Services, Jubilant Biosys, Qiagen NV, Eurofins Scientific SE, Dr. Reddy’s Laboratories, Pharmaron Beijing Co Ltd Ordinary Shares - Class H, TCG Lifesciences, Syngene, Oncodesign, DiscoveRX, Domainex |
Other key industry trends
- In terms of revenue, South Korea accounted for 1.2% of the global drug discovery outsourcing market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, Japan drug discovery outsourcing market is projected to lead the regional market in terms of revenue in 2033.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 497.7 million by 2033.
Supportive government reforms are anticipated to drive the market in South Korea. Furthermore, in September 2019, the Ministry of Food and Drug Safety announced a 5- year plan to improve clinical trials in South Korea.
The plan included three strategies, which involved improving international competitiveness in clinical trials; the development of a clinical trial safety management system; and expanding treatment opportunities & communication systems for patients. Such initiatives by the government are likely to improve the market in South Korea to a certain extent.
No credit card required*
Publish Date: Jul 23, 2025
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Drug Discovery Outsourcing Market Scope
Drug Discovery Outsourcing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Eurofins Scientific SE | View profile | 61,798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | www.eurofins.com |
| Charles River Laboratories International Inc | View profile | 21,400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | www.criver.com |
| Merck & Co Inc | View profile | 72,000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | www.merck.com |
| Labcorp Holdings Inc | View profile | 67,000 | 358 South Main Street, Burlington, NC, United States, 27215 | www.labcorp.com |
| Dr. Reddy’s Laboratories | View profile | 10001+ | Hyderabad, Andhra Pradesh, India, Asia | www.drreddys.com/ |
| Wuxi AppTec Co Ltd | View profile | 41,116 | 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China, People's Republic of, 200131 | www.wuxiapptec.com |
| Evotec SE | View profile | 5,055 | Essener Bogen 7, Manfred Eigen Campus, Hamburg, Germany, 22419 | www.evotec.com |
| GenScript ProBio | View profile | 1001-5000 | Nanjing, Jiangsu, China, Asia | www.genscriptprobio.cn |
South Korea Drug Discovery Outsourcing Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Drug Discovery Outsourcing Market Outlook will help companies and investors design strategic landscapes.
Lead Identification & Candidate Optimization was the largest segment with a revenue share of 34.54% in 2025.
Horizon Databook has segmented the South Korea drug discovery outsourcing market based on target identification & screening, target validation & functional informatics, lead identification & candidate optimization, preclinical development, other associated workflow covering the revenue growth of each sub-segment from 2021 to 2033.
Supportive government reforms are anticipated to drive the market in South Korea. Furthermore, in September 2019, the Ministry of Food and Drug Safety announced a 5- year plan to improve clinical trials in South Korea.
The plan included three strategies, which involved improving international competitiveness in clinical trials; the development of a clinical trial safety management system; and expanding treatment opportunities & communication systems for patients. Such initiatives by the government are likely to improve the market in South Korea to a certain extent.
- South Korea Drug Discovery Outsourcing Market Workflow Outlook (Revenue, USD Million , 2021-2033)
- Target Identification & Screening
- Target Validation & Functional Informatics
- Lead Identification & Candidate Optimization
- Preclinical Development
- Other Associated Workflow
- South Korea Drug Discovery Outsourcing Market Molecule Outlook (Revenue, USD Million , 2021-2033)
- Small Molecules
- Large Molecules
- South Korea Drug Discovery Outsourcing Market Service Outlook (Revenue, USD Million , 2021-2033)
- Chemistry Services
- Biology Services
- South Korea Drug Discovery Outsourcing Market Therapeutics Area Outlook (Revenue, USD Million , 2021-2033)
- Respiratory system
- Pain and Anesthesia
- Oncology
- Ophthalmology
- Hematology
- Cardiovascular
- Endocrine
- Gastrointestinal
- Immunomodulation
- Anti-infective
- Central Nervous System
- Dermatology
- Genitourinary System
- Others
- South Korea Drug Discovery Outsourcing Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Pharmaceutical & Biotechnology companies
- Academic Institutes
Reasons to subscribe to Drug Discovery Outsourcing Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Drug Discovery Outsourcing Market Outlook databook
- Our clientele includes a mix of Drug Discovery Outsourcing Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea Drug Discovery Outsourcing Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into South Korea Drug Discovery Outsourcing Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
South Korea Drug Discovery Outsourcing Market, 2021-2033 (US$M)
South Korea Workflow - Drug Discovery Outsourcing Market Statistics, 2025 - 2033 (US$M)
